We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KDP:NASDAQKeurig Dr Pepper Inc. Analysis

Data as of 2026-09-07 - not real-time

$32.59

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At $32.59, Keurig Dr Pepper Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 9.8% over the past 30 days. Momentum indicators put RSI at 59.0 (neutral) with MACD reading bullish. Watch $28.66 as support and $33.17 as the nearer resistance level.
Multiples put this in fair territory at a P/E of 32.9. Consensus targets land 11.1% above where the shares trade now. Revenue is growing at 75.6% on a 7.1% profit margin. The 2.82% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 28.4%, a beta of 0.05 and a maximum drawdown of 18.4%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 5/10 conviction.

Top Market Events

Keurig Dr Pepper KDP delivered earnings and revenue surprises of +3.Keurig Dr Pepper stock stays close to $32 following a Q2 2026 earnings beat and reaffirmed full-yearAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting and some less so...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 29.13
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Dividend yield of 2.82% looks stretched against payout coverage
  • Trading above the 200-day average of 29.13

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Dividend yield of 2.82% looks stretched against payout coverage
  • Analyst targets imply +11.1% versus the current price
  • Revenue growth of +75.6%

Key Metrics & Analysis

Financial Health

Revenue Growth75.60%
Profit Margin7.10%
P/E Ratio32.9
ROE5.10%
ROA3.38%
Debt/Equity99.65
P/B Ratio1.8
Op. Cash Flow$2.5B
Free Cash Flow$4.6B

Technical Analysis

TrendBullish
RSI59.0
Support$28.66
Resistance$33.17
MA 20$31.44
MA 50$31.29
MA 200$29.13
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$93.31
Target Price$36.21
Upside/Downside11.10%
GradeFair
TypeGrowth
Dividend Yield2.82%

Risk Assessment

Beta0.05
Volatility28.37%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.